|
|
||||||||
|
|
|||||||||
|
|
Instrumentation & Data Analysis: Data Analysis & ManagementData Analysis & Management Posters |
1 Nuclear Medicine; 2 Pulmonary, North Shore-Long Island Jewish Health System, Manhasset, New York
1630
Objectives: To determine if the perfusion index (PI) can be used as a simple, noninvasive measure of the severity of disease in pts with pulmonary artery hypertension (PAH).
Methods: 22 pts were included in this retrospective investigation: 9 controls & 13 pts with PAH. Controls had no evidence of PAH (mean pulmonary arterial pressure (MPAP) <25 mm Hg & pulmonary capillary wedge pressure (PCWP) <=18 mm Hg). Study pts had PAH (MPAP >= 25mm Hg & PCWP <=18 mm Hg) & no diagnosis of pulmonary embolism. Due to the retrospective nature of the study, the PI was calculated from the posterior perfusion image of a ventilation perfusion scan. Each perfusion image was assessed to determine the percent of extrapulmonary activity vs pulmonary activity. If this activity > 10% of maximum lung value, pts were excluded from the investigation (n=27). PI was computed (Fukuchi et al JNM June 2002) as 100 times the sum of the absolute values of the differences versus controls for the 9 deciles above background.
Results: Linear correlations vs. PI were significant for the following: pulmonary vascular resistance (r=0.81, p=0.00009), total pulmonary vascular resistance (MPAP/cardiac output) (r=0.80, p=0.00013), pulmonary artery systolic pressure (r=0.73, p=0.00018), MPAP (r=0.72, p=0.00022), pulmonary diastolic pressure (r=0.53, p=0.01) and right atrial pressure (r=0.50, p=0.03). Using logistic regression the PI was significant in separating pts with PAH from control pts (
2=5.6, p=0.02).
Conclusions: The data suggest that PI can be used for the noninvasive diagnosis & measurement of severity of pulmonary artery hypertension.
| ||||||||||||||||||||||||||||||||||||||